Nusinersen

    verified Drugs for the treatment of orphan diseases

    Nusinersen — package

    info General information

    Name Nusinersen, 2.4 mg/mL, solution for intrathecal administration
    INN Nusinersen
    Active substance Nusinersen
    Pharmacotherapeutic group Other drugs for the treatment of musculoskeletal disorders. Nusinersen.
    Dosage form Solution for intrathecal administration.
    Packaging

    5 mL of the product in colorless glass vials. 1 vial with the product in a cardboard box.

    Manufacturer Karaganda Pharmaceutical Complex LLP EU GMP

    assignment_turned_in Indications

    Nusinersen is indicated for the treatment of 5q spinal muscular atrophy in adults and children.